share_log

ONEONCOLOGY TO ACQUIRE LEADING UROLOGY SPECIALTY PRACTICE NETWORK

ONEONCOLOGY TO ACQUIRE LEADING UROLOGY SPECIALTY PRACTICE NETWORK

ONEONCOLOGY將收購領先的泌尿外科專業診所網絡
PR Newswire ·  08/20 07:58
  • Partnership provides additional growth capital, supported by OneOncology's investors, TPG and Cencora, to expand comprehensive high-value urology care in physician-owned practices and ambulatory surgery centers
  • Culture of physician leadership and organic growth is highly complementary to OneOncology
  • Increasing complexity of prostate, bladder, and other genitourinary cancers means partnership between OneOncology and United Urology Group will drive meaningful improvement to cancer care
  • 合作提供額外的增長資本,得到OneOncology的投資者TPG和Cencora的支持,以擴展由醫生擁有的實踐和門診手術中心提供的綜合高價值泌尿科護理。
  • 以醫生領導和有機增長爲特色的文化與OneOncology高度契合。
  • 前列腺、膀胱和其他泌尿生殖癌的複雜性不斷增加,OneOncology和United Urology Group之間的合作將對癌症治療產生有意義的改善。

NASHVILLE, Tenn. and OWINGS MILLS, Md., Aug. 20, 2024 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent oncology practices, today announced that it has agreed to acquire United Urology Group ("UUG"), one of the nation's leading urology management services organizations supporting approximately 250 physicians and advanced practice providers with more than 1,300 employees. UUG's vision is to lead the transformation of urology through its commitment to accessible, high quality, and value-based care; patient and employee satisfaction; continuous innovation; and community involvement.

2024年8月20日,田納西州納什維爾和馬里蘭州歐文斯密爾斯(PRNewswire)—OneOncology是獨立腫瘤實踐的最快增長的全國平台,今天宣佈已同意收購United Urology Group(「UUG」),這是美國主要的泌尿科管理服務組織之一,支持約250名醫生和高級實踐提供者,擁有超過1,300名員工。UUG的願景是通過致力於可訪問的、高質量的、基於價值的護理、患者和員工滿意度、持續創新和社區參與來引領泌尿科的變革。

OneOncology, the fastest-growing national platform for independent oncology practices, has agreed to acquire United Urology Group, one of the nation's leading urology management services organizations supporting approximately 250 physicians and advanced practice providers with more than 1,300 employees.
OneOncology是獨立腫瘤實踐的最快增長的全國平台之一,已同意收購United Urology Group,這是美國主要的泌尿科管理服務組織之一,支持約250名醫生和高級實踐提供者,擁有超過1,300名員工。

"UUG's attention and dedication to physician centricity and partnership with its leading independent practices is directly aligned with OneOncology's culture and philosophy," said Jeff Patton, MD, Chief Executive Officer, OneOncology. "We are thrilled to partner with the physician and executive leadership of United Urology Group to continue advancing urology care, including the increasingly complex treatment of genitourinary cancers."

「UUG致力於以醫生爲中心的文化和與其領先的獨立實踐合作的夥伴關係與OneOncology的文化和哲學完全一致,」Jeff Patton醫學博士,首席執行官,OneOncology說。「我們很高興與United Urology Group的醫生和執行領導合作,繼續推進泌尿科護理,包括越來越複雜的泌尿生殖癌的治療。」

Urologists are critical members of the cancer care ecosystem, serving as the quarterbacks for cancer care for prostate, bladder, and other genitourinary cancers. Prostate cancer incidence rates have grown by approximately 3% per year over the last decade, creating a high unmet need for these services. In 2024, the American Cancer Society estimates there to be almost 300,000 newly diagnosed cases of prostate cancer in the United States with prostate cancer being the second-leading cause of cancer death in American men.

泌尿科醫生是癌症護理生態系統的重要成員,是前列腺、膀胱和其他泌尿生殖癌症治療的領隊。近10年來,前列腺癌的發病率每年增長約3%,創造了巨大的未滿足需求。2024年,美國癌症協會估計,美國將有近30萬新診斷病例的前列腺癌,前列腺癌是美國男性癌症死亡的第二大原因。

"We at UUG have built something truly unique in the urologic space, offering affiliate practices the support they need to elevate their services while reducing administrative and financial burdens for physicians. I am incredibly proud of our team and excited about the opportunity to unite these two outstanding organizations. With OneOncology's proven track record of growth, we are eager to extend our fully integrated care ecosystem to more independent urology practices. We look forward to enhancing access to high-quality ancillary services for both practices and their patients," said Ian Wong, Chief Executive Officer, UUG.

「我們在泌尿學空間中建立了非常獨特的東西,爲合作醫療提供了所需的支持,提高了服務水平,同時減輕了醫生的行政和財務負擔。我爲我們的團隊感到非常自豪,併爲將這兩個傑出的組織聯繫在一起的機會感到興奮。隨着OneOncology業務增長的卓越記錄,我們渴望將完全融合的護理生態系統擴展到更多的獨立泌尿科實踐中。我們期待增強獨立實踐和患者的高質量輔助服務的可訪問性,」UUG的首席執行官Ian Wong說。

United Urology Group has demonstrated unparalleled operational leadership, integrating its affiliate practices with sophisticated technology systems and processes. This has enabled the company to broaden the breadth of ancillary service lines its affiliate practices provide by offering comprehensive, lower-cost and integrated care to its patients in its physician offices and ambulatory surgery centers. With these capabilities, UUG has created a platform for sustainable growth, partnering with its affiliated practices and providers to improve their economics while maintaining a high level of patient care.

聯合泌尿醫學組織展示了無與倫比的操作領導力,通過提供綜合的、低成本的、整合的護理服務,在醫生的辦公室和門診手術中心爲患者提供了更廣泛的輔助服務線。憑藉這些能力,UUG已經創造了一種可持續增長的平台,與其關聯的實踐和提供者合作,改善其經濟水平,同時保持高水平的患者護理。

"I am energized about the opportunities that this new relationship brings. The synergies between OneOncology and United Urology Group are going to allow us to enhance care to our complex urologic oncology patients and provide the ideal patient experience to all our urology patients across our expanding platform," said Geoffrey Sklar, MD, Chief Medical Officer, UUG.

「我爲這種新關係所帶來的機會感到興奮。 OneOncology和United Urology Group之間的協同效應將允許我們加強對複雜泌尿腫瘤患者的護理,併爲我們擴大平台的所有泌尿科患者提供理想的患者體驗。」UUG的首席醫療官Geoffrey Sklar說。

Debevoise & Plimpton LLP and Sheppard Mullin served as legal counsel to OneOncology, while Ropes & Gray LLP and McGuire Woods served in the same capacity to the seller. Houlihan Lokey served as financial advisor to UUG. The transaction is expected to close by the end of 2024.

Debevoise&Plimpton LLP和Sheppard Mullin擔任OneOncology的法律顧問,而Ropes&Gray LLP和McGuire Woods則作爲出售方的法律顧問。Houlihan Lokey擔任UUG的財務顧問。該交易預計將於2024年年底完成。

About OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. The company's goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. Backed by TPG and Cencora, OneOncology supports its platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. The company's 1,300 cancer care providers care for approximately 787,000 patients at more than 420 sites of care nationwide. Visit for more information.

關於OneOncology
OneOncology由社區腫瘤科醫生創立,旨在改善所有患有癌症的人的生活。該公司的目標是使社區腫瘤實踐保持獨立,並在醫院設置下以較低的成本改善患者的就醫條件。OneOncology由TPG和Cencora支持,通過團體採購、操作優化、實踐增長和臨床創新支持其社區腫瘤學實踐平台。該公司的1,300名癌症護理提供者在全國超過420個護理地點爲約787,000名患者提供護理。訪問 了解更多信息。

About United Urology Group
United Urology Group supports a urology-specific continuum of care model for providers and patients alike. United Urology Group enables affiliate practices to focus on providing high quality, integrated, and cost-effective urologic care to their patients. More than 1,500 caring, compassionate employees are affiliated with the network, including 160+ physicians and 80+ advanced practice providers, serve 900,000+ patients a year with the goal of superior urologic care. The organization's member groups of urology practices today include Arizona Urology Specialists, located in the greater Phoenix and Scottsdale areas; Arizona Urology Specialists, located in the Tucson metro area; Chesapeake Urology, with offices located throughout Maryland and Eastern Delaware; Colorado Urology, located in the greater Denver, Boulder, and Foothills areas; and Tennessee Urology, serving patients in the greater Knoxville area and Eastern Tennessee.

關於United Urology Group
United Urology Group爲提供商和患者提供尿路科的特定連續護理模式的支持。 United Urology Group使聯盟實踐能夠專注於爲其患者提供高質量、整合和具有成本效益的尿路科護理。該網絡共有超過1,500名關心和有同情心的員工,包括160多名醫生和80多名高級實踐提供者,每年爲900,000名患者提供服務,目標是提供卓越的泌尿科護理。該組織的泌尿科實踐成員包括位於菲尼克斯和斯科茨代爾地區的Arizona Urology Specialists;位於圖森市的Arizona Urology Specialists;遍佈馬里蘭州和東部特拉華州的Chesapeake Urology;位於丹佛、博爾德和山麓地區的科羅拉多尿路科;以及Tennessee Urology,爲位於大諾克斯維爾地區和東部田納西州的患者提供服務。

For press inquiries, please contact:

如有媒體問題,請聯繫:

  • OneOncology: Eric Hoffman at [email protected]
  • United Urology Group: Severa Lynch at [email protected]
  • OneOncology:請發郵件至Eric Hoffman [email protected]
  • United Urology Group:請發郵件至Severa Lynch [email protected]

SOURCE OneOncology, LLC.

來源:OneOncology,LLC.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論